DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Glibornuride

Glibornuride

  • (Trulicity) Pen and the Semaglutide (Ozempic) Pen

    (Trulicity) Pen and the Semaglutide (Ozempic) Pen

  • List of Union Reference Dates A

    List of Union Reference Dates A

  • Metformin Does Not Affect Cancer Risk: a Cohort Study in the U.K

    Metformin Does Not Affect Cancer Risk: a Cohort Study in the U.K

  • Sulfonylurea Review

    Sulfonylurea Review

  • Ehealth DSI [Ehdsi V2.2.2-OR] Ehealth DSI – Master Value Set

    Ehealth DSI [Ehdsi V2.2.2-OR] Ehealth DSI – Master Value Set

  • In Silico Target Based Computational Drug Repositioning of Tolazamide with Canagliflozin

    In Silico Target Based Computational Drug Repositioning of Tolazamide with Canagliflozin

  • The Use of Sequential Pattern Mining to Predict Next Prescribed Medications ⇑ Aileen P

    The Use of Sequential Pattern Mining to Predict Next Prescribed Medications ⇑ Aileen P

  • Glibornuride (BAN, USAN, Rinn) Is Given Orally in the Treatment of Type 2 Diabetes Mel- Glibornurid; Glibornurida; Glibornuridi; Glibornuridum; Ro-6- 4563

    Glibornuride (BAN, USAN, Rinn) Is Given Orally in the Treatment of Type 2 Diabetes Mel- Glibornurid; Glibornurida; Glibornuridi; Glibornuridum; Ro-6- 4563

  • The Risk of TB in Patients with Type 2 Diabetes Initiating Metformin Vs&Nbsp

    The Risk of TB in Patients with Type 2 Diabetes Initiating Metformin Vs&Nbsp

  • Ep 1 700 848 A1

    Ep 1 700 848 A1

  • Development and Validation of an LC-MS/MS Method for The

    Development and Validation of an LC-MS/MS Method for The

  • Oral Anti-Diabetic Agents-Review and Updates

    Oral Anti-Diabetic Agents-Review and Updates

  • Stembook 2018.Pdf

    Stembook 2018.Pdf

  • General Practice Prescribing Trends in England and Wales – Annual Review 2014

    General Practice Prescribing Trends in England and Wales – Annual Review 2014

  • Quality of Medical Products for Diabetes Management: a Systematic Review

    Quality of Medical Products for Diabetes Management: a Systematic Review

  • Comparative Safety and Efficacy of Glibenclamide in the Elderly

    Comparative Safety and Efficacy of Glibenclamide in the Elderly

  • Testing the Bipartite Model of the Sulfonylurea Receptor Binding Site

    Testing the Bipartite Model of the Sulfonylurea Receptor Binding Site

  • Pharmaceutical Composition for Preventing Or Treating Diabetes, Containing Zinc Salt, Cyclo-Hispro and Antidiabetic Drug As Active Ingredients

    Pharmaceutical Composition for Preventing Or Treating Diabetes, Containing Zinc Salt, Cyclo-Hispro and Antidiabetic Drug As Active Ingredients

Top View
  • Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
  • Pharmaabkommen A1 E
  • Taj Pharmaceuticals Ltd. Glibornuride CAS
  • Active Pharmaceutical Ingredient (API) CAS Number 1,4 Butanediol
  • Clinical Trial of Glibornuride in Diabetes Br Med J: First Published As 10.1136/Bmj.3.5982.514 on 30 August 1975
  • Antiaggregatory Activity of Hypoglycaemic Sulphonylureas
  • (12) Patent Application Publication (10) Pub. No.: US 2012/0329780 A1 Thormann Et Al
  • The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
  • Customs Tariff - Schedule Xxi - 1
  • (12) Patent Application Publication (10) Pub. No.: US 2007/0255056A1 Kumar Et Al
  • WO 2U11/132171 Al
  • Tepzz 99 876A T
  • ICADTS Drug List
  • Government Gazette Republic of Namibia
  • The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
  • [3H]Glibenclamide-Binding Protein, a Putative Neuronal
  • SMART Clinical Study Protocol Template
  • ICD-10-CM Table of Drugs 2019


© 2024 Docslib.org    Feedback